| pubmed-article:20470823 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20470823 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:20470823 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
| pubmed-article:20470823 | lifeskim:mentions | umls-concept:C0003826 | lld:lifeskim |
| pubmed-article:20470823 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20470823 | lifeskim:mentions | umls-concept:C1412286 | lld:lifeskim |
| pubmed-article:20470823 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20470823 | pubmed:dateCreated | 2010-7-26 | lld:pubmed |
| pubmed-article:20470823 | pubmed:abstractText | Few studies have investigated the impact of chronic hepatitis B and C infection on antiretroviral therapy (ART) outcomes in sub-Saharan Africa. Hepatotoxicity may be a particular concern in co-infected patients taking nevirapine-stavudine-lamivudine. | lld:pubmed |
| pubmed-article:20470823 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20470823 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20470823 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20470823 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20470823 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20470823 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20470823 | pubmed:issn | 1532-2742 | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:DaviesJJ | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:MooreEE | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:BeechingN JNJ | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:ZijlstraE EEE | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:HartI JIJ | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:FaragherBB | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:ChapondaMM | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:BeadsworthM... | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:MhangoBB | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:NjalaJJ | lld:pubmed |
| pubmed-article:20470823 | pubmed:author | pubmed-author:HoflandH W... | lld:pubmed |
| pubmed-article:20470823 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20470823 | pubmed:volume | 61 | lld:pubmed |
| pubmed-article:20470823 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20470823 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20470823 | pubmed:pagination | 155-63 | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:meshHeading | pubmed-meshheading:20470823... | lld:pubmed |
| pubmed-article:20470823 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20470823 | pubmed:articleTitle | Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection. | lld:pubmed |
| pubmed-article:20470823 | pubmed:affiliation | Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi. | lld:pubmed |
| pubmed-article:20470823 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20470823 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20470823 | lld:pubmed |
